Clinic for Obstetrics, Gynecology und Andrology of Large- and Small Animals, Justus-Liebig-University Giessen, Germany.
Anim Reprod Sci. 2009 Nov;116(1-2):129-38. doi: 10.1016/j.anireprosci.2008.12.011. Epub 2008 Dec 24.
In nonpregnant and pregnant dogs the corpora lutea (CL) are the only source of progesterone (P4) which shows an almost identical secretion pattern until the rapid decrease of P4 prior to parturition. For the nonpregnant dog clear evidence has been obtained that physiological luteal regression is devoid of a functional role of the PGF2alpha-system and seems to depend on the provision of StAR. Yet in pregnant dogs the rapid prepartal luteal regression, coinciding with an increase of PGF2alpha, may be indicative for different regulatory mechanisms. To assess this situation and by applying semi-quantitative Real Time (Taq Man) RT-PCR, expression patterns were determined for the following factors in CL of pregnant and prepartal dogs and of mid-pregnant dogs treated with the antiprogestin Aglepristone: cyclooxygenase 2 (Cox2), prostaglandin E2 synthase (PGES), prostaglandin F2alpha synthase (PGFS), its receptors (EP2, EP4 an FP), the steroidogenic acute regulatory protein (StAR), 3beta-hydroxysteroid-dehydrogenase (3betaHSD) and the progesterone receptor (PR). Peripheral plasma P4 concentrations were determined by RIA. CL were collected via ovariohysterectomy from pregnant bitches (n=3-5) on days 8-12 (Group 1, pre-implantation period), days 18-25 (Group 2, post-implantation period), days 35-40 (Group 3, mid-gestation period) and during the prepartal progesterone decline (Group 4). Additionally, CL were obtained from groups of 5 mid-pregnant dogs (days 40-45) 24h, respectively 72h after the second treatment with Aglepristone. Expression of Cox2 and PGES was highest during the pre-implantation period, that of PGFS and FP during the post-implantation period. EP4 and EP2 revealed a constant expression pattern throughout pregnancy with a prepartal upregulation of EP2. 3betaHSD and StAR decreased significantly from the pre-implatation period to prepartal luteolysis, it was matched by the course of P4 concentrations. Expression of the PR was higher during mid-gestation and prepartal luteolysis than in the two preceding periods. After application of Aglepristone the overall mRNA-expression resembled the situation during prepartal luteolysis except for EP2, which remained unchanged. These data suggest that - as in the nonpregnant bitch - also in the pregnant bitch luteal production of prostaglandins is associated with luteal support rather than luteolysis. On the other hand induction of luteolysis by the PR blocker Aglepristone points to a role of luteal P4 as an autocrine factor in a positive loop feedback system controlling the availability of P4, StAR and 3betaHSD.
在非妊娠和妊娠犬中,黄体(CL)是孕激素(P4)的唯一来源,其分泌模式几乎完全相同,直到分娩前 P4 迅速下降。对于非妊娠犬,已经有明确的证据表明,生理黄体退化没有 PGF2alpha 系统的功能作用,似乎依赖于 StAR 的提供。然而,在妊娠犬中,与 PGF2alpha 增加同时发生的快速分娩前黄体退化可能表明存在不同的调节机制。为了评估这种情况,并通过应用半定量实时(Taq Man)RT-PCR,在妊娠和分娩前犬的 CL 中以及用抗孕激素 Aglepristone 治疗的中期妊娠犬中确定了以下因素的表达模式:环氧化酶 2(Cox2)、前列腺素 E2 合酶(PGES)、前列腺素 F2alpha 合酶(PGFS)、其受体(EP2、EP4 和 FP)、类固醇急性调节蛋白(StAR)、3β-羟甾脱氢酶(3βHSD)和孕激素受体(PR)。外周血浆 P4 浓度通过 RIA 测定。通过卵巢切除术从妊娠母犬(n=3-5)中收集 CL,分别在第 8-12 天(第 1 组,着床前阶段)、第 18-25 天(第 2 组,着床后阶段)、第 35-40 天(第 3 组,中期妊娠阶段)和分娩前 P4 下降期间(第 4 组)。此外,还从第 40-45 天的 5 只中期妊娠犬的 2 组中获得 CL,分别在第二次用 Aglepristone 治疗后 24h 和 72h。在着床前阶段,Cox2 和 PGES 的表达最高,在着床后阶段 PGFS 和 FP 的表达最高。EP4 和 EP2 在整个怀孕期间表现出恒定的表达模式,EP2 在分娩前有上调。3βHSD 和 StAR 从着床前阶段到分娩前黄体溶解显著下降,与 P4 浓度的变化相匹配。PR 的表达在中期妊娠和分娩前黄体溶解期间高于前两个时期。应用 Aglepristone 后,整体 mRNA 表达与分娩前黄体溶解时的情况相似,除了 EP2 保持不变。这些数据表明,与非妊娠母犬一样,妊娠母犬黄体的前列腺素产生与黄体支持有关,而不是黄体溶解。另一方面,PR 阻断剂 Aglepristone 诱导黄体溶解表明黄体 P4 作为一种自分泌因子在控制 P4、StAR 和 3βHSD 可用性的正反馈回路反馈系统中发挥作用。